FI66623C - Molekylkoordinationskomplex och foerfarande foer dess framstaellning - Google Patents

Molekylkoordinationskomplex och foerfarande foer dess framstaellning Download PDF

Info

Publication number
FI66623C
FI66623C FI803848A FI803848A FI66623C FI 66623 C FI66623 C FI 66623C FI 803848 A FI803848 A FI 803848A FI 803848 A FI803848 A FI 803848A FI 66623 C FI66623 C FI 66623C
Authority
FI
Finland
Prior art keywords
polymer
alcohol
weight
cellulose
cellulosic polymer
Prior art date
Application number
FI803848A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI66623B (fi
FI803848L (fi
Inventor
Stewart Thomas Leslie
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of FI803848L publication Critical patent/FI803848L/fi
Publication of FI66623B publication Critical patent/FI66623B/fi
Application granted granted Critical
Publication of FI66623C publication Critical patent/FI66623C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/05—Alcohols; Metal alcoholates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
FI803848A 1979-12-19 1980-12-10 Molekylkoordinationskomplex och foerfarande foer dess framstaellning FI66623C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IE248179 1979-12-19
IE2480/79A IE49324B1 (en) 1979-12-19 1979-12-19 Controlled release compositions
IE248179 1979-12-19
IE248079 1979-12-19

Publications (3)

Publication Number Publication Date
FI803848L FI803848L (fi) 1981-06-20
FI66623B FI66623B (fi) 1984-07-31
FI66623C true FI66623C (fi) 1984-11-12

Family

ID=26319271

Family Applications (1)

Application Number Title Priority Date Filing Date
FI803848A FI66623C (fi) 1979-12-19 1980-12-10 Molekylkoordinationskomplex och foerfarande foer dess framstaellning

Country Status (27)

Country Link
US (1) US4366310A (cs)
EP (1) EP0032004B1 (cs)
JP (1) JPS5698201A (cs)
AU (1) AU541246B2 (cs)
BE (1) BE886711A (cs)
CA (1) CA1168230A (cs)
CS (1) CS228142B2 (cs)
DE (1) DE3048028A1 (cs)
DK (1) DK170347B1 (cs)
EG (1) EG14984A (cs)
ES (1) ES497906A0 (cs)
FI (1) FI66623C (cs)
FR (1) FR2474507B1 (cs)
GB (1) GB2067569B (cs)
GR (1) GR72265B (cs)
HU (1) HU188085B (cs)
IE (1) IE49324B1 (cs)
IL (1) IL61677A (cs)
MX (1) MX158088A (cs)
NL (1) NL187401C (cs)
NO (1) NO152846C (cs)
NZ (1) NZ195793A (cs)
PL (1) PL133079B1 (cs)
PT (1) PT72214B (cs)
SU (1) SU1178326A3 (cs)
YU (1) YU40957B (cs)
ZA (1) ZA807716B (cs)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1211266A (en) * 1982-11-12 1986-09-16 Alfred E. Lauchenauer Shaped semi-solid articles
DE3306621A1 (de) * 1983-02-25 1984-08-30 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von celluloseethern mit einem dimethoxyethan enthaltenden dispergierhilfsmittel
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
DE3750145T2 (de) * 1986-06-10 1994-11-03 Euro Celtique Sa Zusammensetzung mit kontrollierter Freisetzung von Dihydrocodein.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US5055300A (en) * 1988-06-17 1991-10-08 Basic Bio Systems, Inc. Time release protein
US5079005A (en) * 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
US5023080A (en) * 1988-06-17 1991-06-11 Basic Bio Systems, Inc. Time release protein
US5476668A (en) * 1990-08-24 1995-12-19 Shin-Etsu Chemical Co., Ltd. Base for film-coating pharmaceuticals and method for preparing same
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
WO1998056359A2 (de) * 1997-06-13 1998-12-17 Roland Bodmeier Zusammensetzungen, die die wirkstofffreisetzung verzögern
EP1685839B8 (en) 1997-12-22 2013-06-26 Euro-Celtique S.A. Pharmaceutical oral dosage form comprising a combination of an opioid agonist and opioid antagonist
GEP20053614B (en) * 2000-02-08 2005-09-26 Euro Celtique Sa Compositions for Oral Administration Containing Opioid Agonist
CA2446550C (en) 2001-05-11 2012-03-06 Endo Pharmaceuticals, Inc. Abuse-resistant controlled-release opioid dosage form
JP4256259B2 (ja) 2001-07-18 2009-04-22 ユーロ−セルティーク エス．エイ． オキシコドン及びナロキソンの医薬配合物
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US20030157168A1 (en) 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
PT1414451E (pt) 2001-08-06 2009-07-31 Euro Celtique Sa Formulações agonistas de opióides com antagonista libertável e sequestrado
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
ES2627298T3 (es) 2002-04-05 2017-07-27 Mundipharma Pharmaceuticals S.L. Preparación farmacéutica que contiene oxicodona y naloxona
ES2677769T3 (es) 2002-09-20 2018-08-06 Alpharma Pharmaceuticals Llc Subunidad secuestrante y composiciones y procedimientos relacionados
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
ES2653568T3 (es) 2004-06-12 2018-02-07 Collegium Pharmaceutical, Inc. Formulaciones de fármacos para la prevención del abuso
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
RU2445077C2 (ru) 2006-06-19 2012-03-20 АЛФАРМА, Инк. Фармацевтические композиции
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
JP2010159364A (ja) * 2009-01-09 2010-07-22 Kyoto Univ セルロースの高温での着色を抑制する方法
RS58240B1 (sr) 2009-03-10 2019-03-29 Euro Celtique Sa Farmaceutske kombinacije sa trenutnim oslobađanjem koje obuhvataju oksikodon i nalokson
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US9993433B2 (en) * 2010-05-10 2018-06-12 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
ES2408343B2 (es) 2010-05-10 2014-07-17 Euro-Celtique, Sa Composiciones farmacéuticas que comprenden hidromorfona y naloxona
MX344846B (es) 2010-05-10 2017-01-10 Euro-Celtique S A * Combinacion de granulos cargados activos con activos adicionales.
DK2826467T3 (en) 2010-12-22 2017-10-16 Purdue Pharma Lp INCLUDED, MANIPULATION-PROPOSED SLOW-DELIVERY DOSAGE FORMS
PH12013501345A1 (en) 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
HK1218392A1 (zh) 2013-02-05 2017-02-17 Purdue Pharma L.P. 抗篡改的药物制剂
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
WO2015011189A1 (en) 2013-07-23 2015-01-29 Euro-Celtique S.A. A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
EP3068397A1 (en) 2013-11-13 2016-09-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264766A (en) * 1877-09-19 1981-04-28 Hoffmann-La Roche Inc. Immunological diagnostic reagents
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
US3988482A (en) * 1971-08-27 1976-10-26 Toyo Hakka Kogyo Kabushiki Kaisha Menthol glycoside, process for preparing the same and method for releasing menthol therefrom
US3818107A (en) * 1972-09-28 1974-06-18 Brook D Chewing gum with sustained flavor release compositions
US3899439A (en) * 1973-03-12 1975-08-12 Hercules Inc Method of preparing aqueous dispersions of hydroxypropyl cellulose
DE2644678A1 (de) * 1976-10-02 1978-04-06 Dynamit Nobel Ag Verfahren zur herstellung funktionalisierter cellulosen
JPS54105223A (en) * 1977-12-29 1979-08-18 Yamanouchi Pharmaceut Co Ltd Coating agent for solid medicine
US4259355A (en) * 1979-03-05 1981-03-31 International Flavors & Fragrances Inc. Chewing gum containing flavor composition and flavor composition therefor
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals

Also Published As

Publication number Publication date
IE49324B1 (en) 1985-09-18
YU40957B (en) 1986-08-31
DK170347B1 (da) 1995-08-07
BE886711A (fr) 1981-06-17
DK527680A (da) 1981-08-05
EP0032004B1 (en) 1985-05-15
CS228142B2 (en) 1984-05-14
FI66623B (fi) 1984-07-31
PL133079B1 (en) 1985-05-31
JPH0225921B2 (cs) 1990-06-06
NO152846C (no) 1985-11-27
NL187401B (nl) 1991-04-16
NO803836L (no) 1981-06-22
NL187401C (nl) 1991-09-16
IE792480L (en) 1981-06-19
HUT34891A (en) 1985-05-28
HU188085B (en) 1986-03-28
EG14984A (en) 1986-06-30
AU6529880A (en) 1981-06-25
FR2474507B1 (fr) 1986-12-26
PT72214B (en) 1981-11-02
PL228573A1 (cs) 1982-07-19
ES8303489A1 (es) 1983-02-01
EP0032004A2 (en) 1981-07-15
NL8006891A (nl) 1981-07-16
GB2067569B (en) 1983-09-01
EP0032004A3 (en) 1982-07-14
AU541246B2 (en) 1985-01-03
PT72214A (en) 1980-08-01
MX158088A (es) 1989-01-06
NZ195793A (en) 1982-09-14
US4366310A (en) 1982-12-28
FI803848L (fi) 1981-06-20
CA1168230A (en) 1984-05-29
ES497906A0 (es) 1983-02-01
IL61677A (en) 1984-10-31
IL61677A0 (en) 1981-01-30
ZA807716B (en) 1981-12-30
DE3048028A1 (de) 1981-09-10
YU321080A (en) 1983-06-30
GR72265B (cs) 1983-10-10
JPS5698201A (en) 1981-08-07
SU1178326A3 (ru) 1985-09-07
FR2474507A1 (fr) 1981-07-31
NO152846B (no) 1985-08-19
GB2067569A (en) 1981-07-30

Similar Documents

Publication Publication Date Title
FI66623C (fi) Molekylkoordinationskomplex och foerfarande foer dess framstaellning
Lenaerts et al. Controlled release of theophylline from cross-linked amylose tablets
US4842866A (en) Slow release solid preparation
US3773920A (en) Sustained release medicinal composition
FI100219B (fi) Menetelmä farmaseuttisen granulaatin valmistamiseksi
US5456921A (en) Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
DE1258548C2 (de) Verfahren zur Herstellung von Arzneimitteltabletten unter Verwendung von Kunstharzen als die Wirkstoffabgabe verzoegernde Einbettungsmassen
AU653372B2 (en) Controlled release compositions
EP0250374B1 (en) Therapeutic system for controlled release of drugs
EP1429735A2 (de) Verfahren und vorrichtung zur herstellung von granulaten umfassend mindestens einen pharmazeutischen wirkstoff
CA1079638A (en) Coated granules of polyacrylic alkali metal salts and method of producing same
US4267138A (en) Coating ensuring a controlled release of active ingredients of biologically active compositions, particularly pharmaceutical compositions and a process for preparation of biologically active compositions ensuring controlled release of active ingredients
US3836618A (en) Process for the uniform distribution of a drug on a granulated base
DE69325236T2 (de) Pharmazeutische Zusammensetzungen enthaltend Urodeoxycholicsäure
DD209575A5 (de) Verfahren zur herstellung eines pharmazeutischen produktes in anhaltend freisetzender form
FI103015B (fi) Menetelmä tabletti- tai raekoostumuksen valmistamiseksi, joka sisältää lämmölle, valolle ja kosteudelle herkkää aktiivista aineosaa, jolla o n monokliininen kiderakenne
DE4127522A1 (de) Neue masse mit einem hydrophilen polymer und einem davon verschiedenen hydrophilen material
DE112006001853T5 (de) Pharmazeutische Zusammensetzungen, die Clopidogrel-Bisulphat enthalten
GB2215207A (en) Sustained release pharmaceutical dosage units
CN107550881B (zh) 一种非洛地平缓释片及其制备工艺
GB2192128A (en) Production of pharmaceutical unit dosage forms
DE60311796T2 (de) Methode zur verbesserung der oberflächeneigenschaften von tabletten
Makino et al. Importance of gelatinization degree of starch paste binder in hardness and disintegration time of tablets
US4315909A (en) Process for the preparation of solid drug formulations
WAN et al. Action of methylcellulose on disintegration and dissolution properties of tablets

Legal Events

Date Code Title Description
MA Patent expired

Owner name: EURO-CELTIQUE, S.A.